• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 31, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Decoding the Recipe for a Potent Plant-Based Medicine

Bioengineer by Bioengineer
October 8, 2025
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a major scientific breakthrough, researchers at the University of British Columbia’s Okanagan campus have delineated the molecular architecture behind the biosynthesis of mitraphylline, a rare and pharmaceutically promising natural compound. Published recently in the prestigious journal The Plant Cell, this study reveals the enzymatic machinery that tropical plants use to create spirooxindole alkaloids, a chemically intricate family of molecules known for their anti-tumor and anti-inflammatory properties. This advance opens doors for sustainable and scalable synthesis of these potent bioactive compounds through green chemistry approaches.

Spirooxindole alkaloids are characterized by their unique “twisted” ring structures, a stereochemical hallmark that underpins their biological activities. Despite long-standing curiosity, the precise enzymatic mechanisms enabling plants to fashion such complex three-dimensional molecular frameworks remained enigmatic, posing a barrier to both fundamental understanding and practical application. The research team, led by Dr. Thu-Thuy Dang, an expert in natural products biotechnology, has now identified a suite of enzymes responsible for orchestrating these spindle-shaped molecular arrangements.

At the heart of this molecular revelation is the successful characterization of a pair of enzymes pivotal in mitraphylline biosynthesis. One enzyme pre-organizes molecular building blocks into a defined three-dimensional orientation, while the other executes the critical “twisting” step that imparts the hallmark spiro configuration. This discovery effectively fills the missing pieces in the elusive biosynthetic “assembly line,” providing mechanistic insight into nature’s synthetic routes for such complex molecules.

The study’s progress capitalized on state-of-the-art genomic sequencing, with the establishment of a chromosome-level genome for Mitragyna parvifolia, a tropical tree closely related to other kratom species. This genomic roadmap was instrumental in pinpointing candidate enzymes within the plant’s intricate metabolic network. Subsequent biochemical assays validated their roles, shedding light on nature’s enzymatic toolkit for spirooxindole diversification.

Mitraphylline, found naturally only in trace amounts in plants like Mitragyna and Uncaria (commonly known as cat’s claw), has evaded synthetic accessibility due to the intricacy of its molecular configuration and low natural abundance. Traditional extraction methods are unsustainable, while chemical synthesis often struggles with the precise three-dimensional control required for biological activity. The enzyme-driven pathways elucidated by the UBC team now hold promise for bioengineering efforts aiming to produce mitraphylline and related compounds in microbial hosts or plant cell cultures.

Dr. Dang emphasized the broader implications of their findings, noting that the ability to decode and harness these natural enzymatic transformations paves the way for manufacturing complex therapeutic compounds through greener, bio-based methods. This approach could drastically reduce reliance on chemical synthesis routes that often involve toxic reagents and generate hazardous waste, aligning with global goals for sustainability in pharmaceutical production.

Further driving this innovation was the leadership of doctoral student Tuan-Anh Nguyen, whose work disentangled the biosynthetic sequence by functionally characterizing the enzymes and deciphering their three-dimensional catalytic mechanisms. Nguyen’s research benefited from the collaborative and interdisciplinary environment at UBC Okanagan, where faculty and students synergize expertise in biochemistry, molecular biology, and natural product chemistry.

The significance of this study extends beyond mitraphylline itself; it lays a foundational framework for understanding spirooxindole biosynthesis across plant species, unlocking potential for discovery and engineering of analog compounds with tailored pharmacological profiles. This enzymatic “toolkit” could catalyze novel drug development initiatives targeting cancers and inflammatory diseases, domains where effective therapeutic options remain urgently needed.

This ambitious project was a transnational collaboration with Dr. Satya Nadakuduti’s team at the University of Florida, blending complementary scientific strengths in plant genomics and enzymology. Their collaborative spirit amplified the discovery’s impact, underscoring the importance of integrative research networks in unraveling complex biochemical puzzles.

The research received robust funding support from multiple prestigious agencies including the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canada Foundation for Innovation, Health Research BC, and the U.S. Department of Agriculture’s National Institute of Food and Agriculture. This investment reflects the recognized potential of translating fundamental plant biochemical insights into impactful biomedical applications.

Looking ahead, the team intends to expand their enzymatic repertoire to diversify the chemical landscape of therapeutic spirooxindoles. By adapting and optimizing these molecular catalysts, they aim to unlock new frontiers in synthetic biology, enabling sustainable manufacturing of rare natural products that currently pose considerable supply challenges.

In sum, this pioneering work marks a critical advance in natural product chemistry and enzymology. It not only unravels the molecular ballet enabling spirooxindole formation but also charts a bioinspired path to drug discovery and sustainable production. As the scientific community continues to explore nature’s molecular ingenuity, such insights will propel forward the next generation of pharmaceuticals and green biotechnologies.

Subject of Research: Cells

Article Title: A chromosome-level Mitragyna parvifolia genome unveils spirooxindole alkaloid diversification and mitraphylline biosynthesis

News Publication Date: 9-Sep-2025

Web References: http://dx.doi.org/10.1093/plcell/koaf207

Image Credits: UBC Okanagan

Keywords: mitraphylline, spirooxindole alkaloids, natural products biotechnology, enzyme catalysis, plant genomics, sustainable drug synthesis, green chemistry, molecular biosynthesis, anti-tumor compounds, natural product enzymes

Tags: anti-inflammatory compoundsanti-tumor propertiesDr. Thu-Thuy Dang researchenzymes in plant chemistrygreen chemistry approachesmitraphylline biosynthesismolecular architecture of natural compoundsnatural products biotechnologyplant-based medicinespirooxindole alkaloidssustainable synthesis of bioactive compoundsUniversity of British Columbia research

Tags: enzyme catalysisenzyme catalysis in plantsmitraphylline biosynthesisplant-based medicineplant-based pharmaceuticalsspirooxindole alkaloidssustainable drug synthesis
Share13Tweet8Share2ShareShareShare2

Related Posts

Immunotherapy Plus Radiotherapy in Advanced Lung Cancer

October 30, 2025

Moffitt Research Reveals Complementary Approaches to Combat Resistance to KRAS G12C Inhibitors in Lung Cancer

October 30, 2025

Mount Sinai Tisch Cancer Center Unveils Real-Time Data Integration Tool to Accelerate and Enhance Research Accuracy

October 30, 2025

University of South Florida Establishes Pioneering Virology Institute Under the Leadership of Renowned Scientist Dr. Robert C. Gallo

October 30, 2025

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1292 shares
    Share 516 Tweet 323
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    312 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    202 shares
    Share 81 Tweet 51
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    136 shares
    Share 54 Tweet 34

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Researchers Discover Novel Energy Potential in Iron-Based Materials

Impact of Childhood Trauma on Autistic Youth Health

UCSB Experimentalists Awarded Gordon and Betty Moore Foundation Grants to Propel New Insights and Innovations

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.